Structure

Physi-Chem Properties

Molecular Weight:  440.33
Volume:  485.819
LogP:  4.507
LogD:  4.319
LogS:  -5.133
# Rotatable Bonds:  1
TPSA:  54.37
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  5
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.488
Synthetic Accessibility Score:  4.698
Fsp3:  0.862
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.209
MDCK Permeability:  3.0326980777317658e-05
Pgp-inhibitor:  0.718
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.01
30% Bioavailability (F30%):  0.94

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.006
Plasma Protein Binding (PPB):  93.86592864990234%
Volume Distribution (VD):  0.843
Pgp-substrate:  3.3646903038024902%

ADMET: Metabolism

CYP1A2-inhibitor:  0.045
CYP1A2-substrate:  0.557
CYP2C19-inhibitor:  0.19
CYP2C19-substrate:  0.913
CYP2C9-inhibitor:  0.309
CYP2C9-substrate:  0.156
CYP2D6-inhibitor:  0.233
CYP2D6-substrate:  0.096
CYP3A4-inhibitor:  0.789
CYP3A4-substrate:  0.672

ADMET: Excretion

Clearance (CL):  3.325
Half-life (T1/2):  0.114

ADMET: Toxicity

hERG Blockers:  0.022
Human Hepatotoxicity (H-HT):  0.396
Drug-inuced Liver Injury (DILI):  0.078
AMES Toxicity:  0.017
Rat Oral Acute Toxicity:  0.504
Maximum Recommended Daily Dose:  0.917
Skin Sensitization:  0.211
Carcinogencity:  0.008
Eye Corrosion:  0.007
Eye Irritation:  0.041
Respiratory Toxicity:  0.976

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471737

Natural Product ID:  NPC471737
Common Name*:   3Alpha-Hydroxy-30-Norlupan-18(19)-Ene-20,21-Dione
IUPAC Name:   (3aS,5aR,5bR,7aR,9R,11aR,11bR,13aS)-1-acetyl-9-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-2-one
Synonyms:  
Standard InCHIKey:  HFYWMHYYAAQGEB-HRJDOSHVSA-N
Standard InCHI:  InChI=1S/C29H44O3/c1-17(30)23-19(31)16-26(4)14-15-28(6)18(24(23)26)8-9-21-27(5)12-11-22(32)25(2,3)20(27)10-13-29(21,28)7/h18,20-22,32H,8-16H2,1-7H3/t18-,20+,21-,22-,26+,27+,28-,29-/m1/s1
SMILES:  CC(=O)C1=C2[C@H]3CC[C@H]4[C@@]([C@]3(C)CC[C@]2(CC1=O)C)(C)CC[C@@H]1[C@]4(C)CC[C@H](C1(C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3109397
PubChem CID:   76321227
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001194] Oxosteroids
          • [CHEMONTID:0003060] 16-oxosteroids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33010 euonymus carnosus Species Celastraceae Eukaryota Plant n.a. n.a. PMID[24467317]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT179 Cell Line A2780 Homo sapiens IC50 > 10000.0 nM PMID[534105]
NPT81 Cell Line A549 Homo sapiens IC50 > 10000.0 nM PMID[534105]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10000.0 nM PMID[534105]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471737 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.907 High Similarity NPC85173
0.8851 High Similarity NPC126993
0.8837 High Similarity NPC474677
0.8837 High Similarity NPC230387
0.8824 High Similarity NPC158393
0.875 High Similarity NPC272746
0.8736 High Similarity NPC122116
0.8721 High Similarity NPC469314
0.8721 High Similarity NPC241875
0.8721 High Similarity NPC469317
0.8706 High Similarity NPC470574
0.8706 High Similarity NPC133954
0.8706 High Similarity NPC197823
0.869 High Similarity NPC472743
0.869 High Similarity NPC475726
0.8621 High Similarity NPC472802
0.8605 High Similarity NPC475862
0.8605 High Similarity NPC74363
0.8605 High Similarity NPC72133
0.8605 High Similarity NPC213412
0.8588 High Similarity NPC474482
0.8588 High Similarity NPC475745
0.8556 High Similarity NPC471207
0.8539 High Similarity NPC145067
0.8539 High Similarity NPC4036
0.8539 High Similarity NPC233455
0.8539 High Similarity NPC158030
0.8539 High Similarity NPC65120
0.8523 High Similarity NPC469319
0.8523 High Similarity NPC119416
0.8523 High Similarity NPC229871
0.8506 High Similarity NPC141292
0.8506 High Similarity NPC73064
0.8506 High Similarity NPC475740
0.8488 Intermediate Similarity NPC292553
0.8471 Intermediate Similarity NPC86370
0.8444 Intermediate Similarity NPC214756
0.8444 Intermediate Similarity NPC12722
0.8444 Intermediate Similarity NPC295643
0.8444 Intermediate Similarity NPC272075
0.8409 Intermediate Similarity NPC472739
0.8409 Intermediate Similarity NPC206060
0.8409 Intermediate Similarity NPC310752
0.8409 Intermediate Similarity NPC143767
0.8409 Intermediate Similarity NPC292491
0.8409 Intermediate Similarity NPC471722
0.8409 Intermediate Similarity NPC131470
0.8409 Intermediate Similarity NPC328539
0.8409 Intermediate Similarity NPC193360
0.8391 Intermediate Similarity NPC72638
0.8391 Intermediate Similarity NPC31564
0.8391 Intermediate Similarity NPC145879
0.8391 Intermediate Similarity NPC477579
0.8391 Intermediate Similarity NPC95594
0.8391 Intermediate Similarity NPC98236
0.8391 Intermediate Similarity NPC472738
0.8391 Intermediate Similarity NPC474733
0.8391 Intermediate Similarity NPC474732
0.8391 Intermediate Similarity NPC474778
0.8391 Intermediate Similarity NPC269396
0.8391 Intermediate Similarity NPC235341
0.8372 Intermediate Similarity NPC85774
0.8372 Intermediate Similarity NPC214043
0.8372 Intermediate Similarity NPC171789
0.8372 Intermediate Similarity NPC474233
0.8372 Intermediate Similarity NPC264665
0.8372 Intermediate Similarity NPC180834
0.8372 Intermediate Similarity NPC74595
0.8333 Intermediate Similarity NPC473166
0.8315 Intermediate Similarity NPC1015
0.8315 Intermediate Similarity NPC250592
0.8315 Intermediate Similarity NPC77263
0.8315 Intermediate Similarity NPC86319
0.8315 Intermediate Similarity NPC275740
0.8315 Intermediate Similarity NPC31985
0.8315 Intermediate Similarity NPC309603
0.8315 Intermediate Similarity NPC69627
0.8315 Intermediate Similarity NPC473999
0.8295 Intermediate Similarity NPC142415
0.8295 Intermediate Similarity NPC307426
0.8295 Intermediate Similarity NPC4643
0.8295 Intermediate Similarity NPC93778
0.8295 Intermediate Similarity NPC68160
0.8295 Intermediate Similarity NPC293564
0.8295 Intermediate Similarity NPC242468
0.8295 Intermediate Similarity NPC102683
0.8295 Intermediate Similarity NPC18064
0.8295 Intermediate Similarity NPC171203
0.8295 Intermediate Similarity NPC130577
0.8295 Intermediate Similarity NPC98442
0.8295 Intermediate Similarity NPC57469
0.8295 Intermediate Similarity NPC58063
0.8295 Intermediate Similarity NPC88716
0.8295 Intermediate Similarity NPC51700
0.8276 Intermediate Similarity NPC294438
0.8276 Intermediate Similarity NPC264317
0.8276 Intermediate Similarity NPC76518
0.8261 Intermediate Similarity NPC473170
0.8261 Intermediate Similarity NPC148523
0.8261 Intermediate Similarity NPC139570
0.8242 Intermediate Similarity NPC274046
0.8242 Intermediate Similarity NPC198074
0.8242 Intermediate Similarity NPC475255
0.8235 Intermediate Similarity NPC3915
0.8235 Intermediate Similarity NPC328264
0.8235 Intermediate Similarity NPC473217
0.8222 Intermediate Similarity NPC191684
0.8222 Intermediate Similarity NPC183283
0.8222 Intermediate Similarity NPC291028
0.8222 Intermediate Similarity NPC48010
0.8214 Intermediate Similarity NPC201459
0.8202 Intermediate Similarity NPC474512
0.8202 Intermediate Similarity NPC290690
0.8202 Intermediate Similarity NPC471724
0.8202 Intermediate Similarity NPC474719
0.8202 Intermediate Similarity NPC17733
0.8202 Intermediate Similarity NPC474925
0.8202 Intermediate Similarity NPC182797
0.8202 Intermediate Similarity NPC40552
0.8202 Intermediate Similarity NPC470629
0.8202 Intermediate Similarity NPC181225
0.8202 Intermediate Similarity NPC52169
0.8202 Intermediate Similarity NPC246708
0.8202 Intermediate Similarity NPC473242
0.8193 Intermediate Similarity NPC472746
0.8182 Intermediate Similarity NPC12774
0.8182 Intermediate Similarity NPC2783
0.8182 Intermediate Similarity NPC56588
0.8172 Intermediate Similarity NPC98874
0.8171 Intermediate Similarity NPC97534
0.8171 Intermediate Similarity NPC195155
0.8171 Intermediate Similarity NPC174964
0.8161 Intermediate Similarity NPC161423
0.8161 Intermediate Similarity NPC227064
0.8161 Intermediate Similarity NPC329043
0.8161 Intermediate Similarity NPC473157
0.8161 Intermediate Similarity NPC321187
0.8161 Intermediate Similarity NPC473246
0.8161 Intermediate Similarity NPC58841
0.8161 Intermediate Similarity NPC59453
0.8161 Intermediate Similarity NPC221758
0.8152 Intermediate Similarity NPC196485
0.8152 Intermediate Similarity NPC23170
0.8152 Intermediate Similarity NPC111015
0.8152 Intermediate Similarity NPC245972
0.8152 Intermediate Similarity NPC74751
0.814 Intermediate Similarity NPC48362
0.814 Intermediate Similarity NPC310989
0.814 Intermediate Similarity NPC151519
0.814 Intermediate Similarity NPC469325
0.814 Intermediate Similarity NPC163236
0.8132 Intermediate Similarity NPC473167
0.8132 Intermediate Similarity NPC473998
0.8132 Intermediate Similarity NPC110657
0.8132 Intermediate Similarity NPC475806
0.8132 Intermediate Similarity NPC155304
0.8132 Intermediate Similarity NPC168027
0.8132 Intermediate Similarity NPC185936
0.8132 Intermediate Similarity NPC63748
0.8132 Intermediate Similarity NPC474525
0.8132 Intermediate Similarity NPC131872
0.8132 Intermediate Similarity NPC105189
0.8132 Intermediate Similarity NPC233116
0.8132 Intermediate Similarity NPC86266
0.8132 Intermediate Similarity NPC212301
0.8118 Intermediate Similarity NPC18955
0.8118 Intermediate Similarity NPC2482
0.8111 Intermediate Similarity NPC59263
0.8111 Intermediate Similarity NPC25906
0.8111 Intermediate Similarity NPC198664
0.8111 Intermediate Similarity NPC95246
0.8111 Intermediate Similarity NPC474972
0.8111 Intermediate Similarity NPC293048
0.8111 Intermediate Similarity NPC474686
0.8111 Intermediate Similarity NPC64872
0.8111 Intermediate Similarity NPC234346
0.8111 Intermediate Similarity NPC127689
0.8111 Intermediate Similarity NPC186688
0.8111 Intermediate Similarity NPC130520
0.8111 Intermediate Similarity NPC270768
0.8111 Intermediate Similarity NPC26959
0.8111 Intermediate Similarity NPC274330
0.8111 Intermediate Similarity NPC121798
0.8111 Intermediate Similarity NPC263393
0.8111 Intermediate Similarity NPC143232
0.8111 Intermediate Similarity NPC290972
0.8111 Intermediate Similarity NPC61543
0.8111 Intermediate Similarity NPC470588
0.8111 Intermediate Similarity NPC268406
0.8111 Intermediate Similarity NPC225585
0.8111 Intermediate Similarity NPC161751
0.809 Intermediate Similarity NPC269360
0.809 Intermediate Similarity NPC142361
0.809 Intermediate Similarity NPC33768
0.809 Intermediate Similarity NPC474684
0.809 Intermediate Similarity NPC469322
0.809 Intermediate Similarity NPC138756
0.809 Intermediate Similarity NPC264005
0.8072 Intermediate Similarity NPC475742
0.8072 Intermediate Similarity NPC5767

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471737 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8605 High Similarity NPD3618 Phase 1
0.8539 High Similarity NPD7515 Phase 2
0.8523 High Similarity NPD5328 Approved
0.8333 Intermediate Similarity NPD6079 Approved
0.8276 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.8161 Intermediate Similarity NPD4786 Approved
0.8161 Intermediate Similarity NPD3666 Approved
0.8161 Intermediate Similarity NPD3133 Approved
0.8161 Intermediate Similarity NPD3665 Phase 1
0.8152 Intermediate Similarity NPD7748 Approved
0.814 Intermediate Similarity NPD3667 Approved
0.8043 Intermediate Similarity NPD4202 Approved
0.7895 Intermediate Similarity NPD7902 Approved
0.7882 Intermediate Similarity NPD3617 Approved
0.7805 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7805 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7789 Intermediate Similarity NPD5222 Approved
0.7789 Intermediate Similarity NPD5221 Approved
0.7789 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7789 Intermediate Similarity NPD4697 Phase 3
0.7778 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7708 Intermediate Similarity NPD5173 Approved
0.7708 Intermediate Similarity NPD4755 Approved
0.764 Intermediate Similarity NPD4788 Approved
0.7609 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD7645 Phase 2
0.7582 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD5279 Phase 3
0.7579 Intermediate Similarity NPD7900 Approved
0.7579 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7553 Intermediate Similarity NPD8034 Phase 2
0.7553 Intermediate Similarity NPD8035 Phase 2
0.7551 Intermediate Similarity NPD4700 Approved
0.7551 Intermediate Similarity NPD5286 Approved
0.7551 Intermediate Similarity NPD5285 Approved
0.7551 Intermediate Similarity NPD4696 Approved
0.7529 Intermediate Similarity NPD3703 Phase 2
0.7528 Intermediate Similarity NPD4221 Approved
0.7528 Intermediate Similarity NPD4223 Phase 3
0.7527 Intermediate Similarity NPD4753 Phase 2
0.75 Intermediate Similarity NPD7525 Registered
0.7475 Intermediate Similarity NPD5223 Approved
0.7473 Intermediate Similarity NPD5329 Approved
0.747 Intermediate Similarity NPD4245 Approved
0.747 Intermediate Similarity NPD4244 Approved
0.7449 Intermediate Similarity NPD7638 Approved
0.7442 Intermediate Similarity NPD6117 Approved
0.7412 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD5225 Approved
0.74 Intermediate Similarity NPD4633 Approved
0.74 Intermediate Similarity NPD5226 Approved
0.74 Intermediate Similarity NPD5224 Approved
0.74 Intermediate Similarity NPD5211 Phase 2
0.7391 Intermediate Similarity NPD7334 Approved
0.7391 Intermediate Similarity NPD6684 Approved
0.7391 Intermediate Similarity NPD7146 Approved
0.7391 Intermediate Similarity NPD7521 Approved
0.7391 Intermediate Similarity NPD6409 Approved
0.7391 Intermediate Similarity NPD5330 Approved
0.7374 Intermediate Similarity NPD7639 Approved
0.7374 Intermediate Similarity NPD7640 Approved
0.7363 Intermediate Similarity NPD3668 Phase 3
0.7363 Intermediate Similarity NPD4197 Approved
0.7356 Intermediate Similarity NPD6116 Phase 1
0.7353 Intermediate Similarity NPD6675 Approved
0.7353 Intermediate Similarity NPD7128 Approved
0.7353 Intermediate Similarity NPD5739 Approved
0.7353 Intermediate Similarity NPD6402 Approved
0.7349 Intermediate Similarity NPD3698 Phase 2
0.7327 Intermediate Similarity NPD5174 Approved
0.7327 Intermediate Similarity NPD5175 Approved
0.7327 Intermediate Similarity NPD4754 Approved
0.7292 Intermediate Similarity NPD6399 Phase 3
0.7273 Intermediate Similarity NPD6114 Approved
0.7273 Intermediate Similarity NPD6115 Approved
0.7273 Intermediate Similarity NPD6697 Approved
0.7273 Intermediate Similarity NPD6118 Approved
0.7262 Intermediate Similarity NPD4789 Approved
0.7255 Intermediate Similarity NPD5141 Approved
0.7234 Intermediate Similarity NPD6903 Approved
0.7229 Intermediate Similarity NPD5361 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD5360 Phase 3
0.7228 Intermediate Similarity NPD7632 Discontinued
0.7212 Intermediate Similarity NPD6899 Approved
0.7212 Intermediate Similarity NPD6881 Approved
0.7212 Intermediate Similarity NPD7320 Approved
0.7204 Intermediate Similarity NPD4690 Approved
0.7204 Intermediate Similarity NPD4623 Approved
0.7204 Intermediate Similarity NPD4138 Approved
0.7204 Intermediate Similarity NPD4688 Approved
0.7204 Intermediate Similarity NPD4519 Discontinued
0.7204 Intermediate Similarity NPD5205 Approved
0.7204 Intermediate Similarity NPD4693 Phase 3
0.7204 Intermediate Similarity NPD4689 Approved
0.7184 Intermediate Similarity NPD4768 Approved
0.7184 Intermediate Similarity NPD4767 Approved
0.7172 Intermediate Similarity NPD6084 Phase 2
0.7172 Intermediate Similarity NPD6083 Phase 2
0.7158 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5210 Approved
0.7143 Intermediate Similarity NPD6373 Approved
0.7143 Intermediate Similarity NPD4629 Approved
0.7143 Intermediate Similarity NPD6372 Approved
0.7126 Intermediate Similarity NPD6942 Approved
0.7126 Intermediate Similarity NPD7339 Approved
0.7115 Intermediate Similarity NPD5697 Approved
0.7115 Intermediate Similarity NPD5701 Approved
0.7111 Intermediate Similarity NPD4695 Discontinued
0.7079 Intermediate Similarity NPD3671 Phase 1
0.7075 Intermediate Similarity NPD7102 Approved
0.7075 Intermediate Similarity NPD6883 Approved
0.7075 Intermediate Similarity NPD7290 Approved
0.7073 Intermediate Similarity NPD3171 Clinical (unspecified phase)
0.7053 Intermediate Similarity NPD6672 Approved
0.7053 Intermediate Similarity NPD5737 Approved
0.7048 Intermediate Similarity NPD4730 Approved
0.7048 Intermediate Similarity NPD6011 Approved
0.7048 Intermediate Similarity NPD4729 Approved
0.7048 Intermediate Similarity NPD5168 Approved
0.7048 Intermediate Similarity NPD5128 Approved
0.7045 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7033 Intermediate Similarity NPD4692 Approved
0.7033 Intermediate Similarity NPD4139 Approved
0.7021 Intermediate Similarity NPD5690 Phase 2
0.7021 Intermediate Similarity NPD4694 Approved
0.7021 Intermediate Similarity NPD5280 Approved
0.7009 Intermediate Similarity NPD6650 Approved
0.7009 Intermediate Similarity NPD8130 Phase 1
0.7009 Intermediate Similarity NPD6847 Approved
0.7009 Intermediate Similarity NPD6617 Approved
0.7009 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7009 Intermediate Similarity NPD6649 Approved
0.7009 Intermediate Similarity NPD6869 Approved
0.6981 Remote Similarity NPD6012 Approved
0.6981 Remote Similarity NPD6014 Approved
0.6981 Remote Similarity NPD6013 Approved
0.6952 Remote Similarity NPD6412 Phase 2
0.6947 Remote Similarity NPD3573 Approved
0.6944 Remote Similarity NPD8297 Approved
0.6944 Remote Similarity NPD6882 Approved
0.6941 Remote Similarity NPD4137 Phase 3
0.6916 Remote Similarity NPD5249 Phase 3
0.6916 Remote Similarity NPD5250 Approved
0.6916 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6916 Remote Similarity NPD5247 Approved
0.6916 Remote Similarity NPD5135 Approved
0.6916 Remote Similarity NPD5251 Approved
0.6916 Remote Similarity NPD5169 Approved
0.6916 Remote Similarity NPD5248 Approved
0.6916 Remote Similarity NPD4634 Approved
0.686 Remote Similarity NPD4747 Approved
0.686 Remote Similarity NPD4691 Approved
0.6852 Remote Similarity NPD5127 Approved
0.6852 Remote Similarity NPD5215 Approved
0.6852 Remote Similarity NPD5216 Approved
0.6852 Remote Similarity NPD5217 Approved
0.6847 Remote Similarity NPD7115 Discovery
0.6813 Remote Similarity NPD4195 Approved
0.68 Remote Similarity NPD6356 Clinical (unspecified phase)
0.68 Remote Similarity NPD5695 Phase 3
0.6782 Remote Similarity NPD4758 Discontinued
0.6765 Remote Similarity NPD5290 Discontinued
0.6765 Remote Similarity NPD5696 Approved
0.6757 Remote Similarity NPD6868 Approved
0.6739 Remote Similarity NPD4748 Discontinued
0.6733 Remote Similarity NPD7614 Phase 1
0.6727 Remote Similarity NPD4632 Approved
0.6667 Remote Similarity NPD7341 Phase 2
0.6667 Remote Similarity NPD5281 Approved
0.6667 Remote Similarity NPD5167 Approved
0.6667 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5284 Approved
0.6637 Remote Similarity NPD6335 Approved
0.6633 Remote Similarity NPD6080 Approved
0.6633 Remote Similarity NPD6904 Approved
0.6633 Remote Similarity NPD6673 Approved
0.6629 Remote Similarity NPD4058 Approved
0.6629 Remote Similarity NPD6924 Approved
0.6629 Remote Similarity NPD6926 Approved
0.6629 Remote Similarity NPD5733 Approved
0.6607 Remote Similarity NPD6274 Approved
0.66 Remote Similarity NPD5133 Approved
0.6591 Remote Similarity NPD6081 Approved
0.6591 Remote Similarity NPD5777 Approved
0.6588 Remote Similarity NPD4224 Phase 2
0.6579 Remote Similarity NPD7100 Approved
0.6579 Remote Similarity NPD7101 Approved
0.6566 Remote Similarity NPD4096 Approved
0.6562 Remote Similarity NPD1696 Phase 3
0.6562 Remote Similarity NPD1694 Approved
0.6559 Remote Similarity NPD8259 Clinical (unspecified phase)
0.6559 Remote Similarity NPD7509 Discontinued
0.6552 Remote Similarity NPD4267 Clinical (unspecified phase)
0.6549 Remote Similarity NPD6009 Approved
0.6549 Remote Similarity NPD6317 Approved
0.6542 Remote Similarity NPD6008 Approved
0.6535 Remote Similarity NPD6001 Approved
0.6531 Remote Similarity NPD5208 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data